Anders Neijber joined Photocure in August 2021, bringing over 25 years of substantial experience in the uro-oncology area and successful leadership in the pharmaceutical industry. He has had global and regional assignments, both in the U.S. and Europe, within Clinical R&D and Medical Affairs, having worked for Pfizer, AstraZeneca, Johnson&Johnson, Allergan and Ferring, where he held a similar global Medical Affairs leadership role as V.P., Global Therapeutic Area Head Uro-Oncology. Most recently he worked in Medical Affairs for Novartis in the Nordics.
Anders completed his MD and PhD from Karolinska University, is a board certified urologist, and also holds an MBA from Western Michigan University. He held an assistant Professor position at the Department of Clinical Pharmacology, Robert Wood Johnson Medical School, New Jersey.
Anders Neijber holds 20,000 share options in Photocure.